Skip to main content

Table 2 Anthropometric and clinical characteristics in migraine patients with and without cutaneous allodynia

From: Excess abdominal fat is associated with cutaneous allodynia in individuals with migraine: a prospective cohort study

Variables

Migraineurs with CA (n = 43)

Migraineurs without CA (n = 37)

p-value a

Age (years)

41 ± 11

37 ± 9

0.05

Female (%)

86.5%

75.7%

0.24

Height (m)

1.64 ± 0.09

1.65 ± 0.08

0.52

Weight (kg)

64.7 ± 11.2

64.1 ± 12.4

0.79

BMI (kg/m2)

24.1 ± 3.9

23.4 ± 3.1

0.42

Body composition – ViScan abdominal fat

35.7 ± 8.7

32.9 ± 7.5

0.04

Body fat percentage

32.6 ± 9.4

31.1 ± 7.78

0.07

HIT-6

62.68 ± 7.19

58.47 ± 9.03

0.03

MIDAS

54.83 ± 57.83

29.03 ± 40.09

0.05

Migraine evolution (years)

9.9 ± 8.6

9.7 ± 10.3

0.03

Frequency (attacks per month)

9.49 ± 8.70

5.25 ± 5.17

0.23

 1–9 days per month

23 (53.5%)

28 (75.0%)

 

 10–14 days per month

1 (2.3%)

1 (2.8%)

0.31 b

 >  15 days per month

19 (44.2%)

8 (22.2%)

 

Analgesic consumption (last month)

11.32 ± 8.01

7.36 ± 7.39

0.03

Triptan consumption (last month)

4.47 ± 6.69

3.05 ± 6.51

0.464

Medication overuse

21 (48.8%)

10 (27.0%)

0.726 b

Use of migraine prophylaxis

25 (59.5%)

12 (32.4%)

0.02 b

Depression (%)

16.2%

10.8%

0.49 b

Anxiety disorders (%)

37.2%

37.5%

0.95 b

Sleep disorders (%)

69.8%

43.2%

0.02 b

  1. Anxiety and mood disorders as well as sleep disorders were self-reported
  2. BMI body mass index, CA cutaneous allodynia, HIT-6 6-item Headache Impact Test, MIDAS Migraine Disability Assessment
  3. a Two-tailed independent samples Student’s t/Mann–Whitney U tests
  4. b Chi-squared test